BioMerieux Sole Source - Not Accepting Bids

The Oregon Health Authority (OHA), specifically the Oregon State Public Health Laboratory (OSPHL), is pursuing a sole source procurement from bioMerieux for a BioFire FilmArray Torch PCR Assay System and associated maintenance, service agreements, reagents, and supplies. This procurement is designed to replace a discontinued BioFire FilmArray 2.0 System and ensure continuity of COVID-19 and communicable disease testing operations. The goods include the Torch System, compatible reagents, and comprehensive service agreements, with specific focus on maintaining warranty compliance and testing capabilities. BioMerieux is identified as the exclusive manufacturer, distributor, and service provider for these specialized diagnostic products, which include BIOFIRE FILMARRAY TORCH System, VITEK systems, and related software. The procurement is structured as a sole source contract, with a contract opportunity ID of 66b0b9f2455dd5ad9e090638, posted on August 1, 2024, and with responses due by August 8, 2024. The key objective is to maintain the laboratory's diagnostic testing infrastructure without interruption, leveraging existing technological investments and ensuring seamless operational continuity.

This procurement is not subject to competitive bidding, as bioMerieux is the sole authorized source for these specialized diagnostic systems. No specific set-aside designations or restrictions for disadvantaged enterprises are mentioned in the documentation. The contract is estimated at $500,000 over a five-year period, with an option to renew for an additional five years. The current infrastructure includes a discontinued BioFire FilmArray 2.0 System, which necessitates continued procurement from the same manufacturer to maintain system compatibility and warranty integrity. The procurement is specifically targeted at U.S. government customers, including state public health laboratories, with a focus on maintaining critical diagnostic testing capabilities. The contract will cover all bioMerieux and BioFire diagnostic systems, software, and associated reagents, ensuring the Oregon Health Authority can continue its communicable disease testing operations without interruption. No alternative vendors or competitive bidding is permitted under this sole source determination.